Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

First Pass Effect01:12

First Pass Effect

9.7K
Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
9.7K
Distance Corrections01:15

Distance Corrections

303
To achieve precise distance measurements, especially in surveying and construction, certain corrections must be applied to account for potential sources of error like the standardization errors, temperature variations, and slope adjustments.Standardization error emerges when measurement equipment undergoes changes, such as wear, repairs, or weather impacts. To address this, surveyors compare the equipment’s readings to a standard. This process identifies any deviation that might lead to...
303
Power Factor Correction01:20

Power Factor Correction

562
The power transmission to a factory involves the transfer of apparent power, a combination of active and reactive power. The power factor measures how effectively electrical power is converted into useful work output. The ratio of the real power (KW) that does the work to the apparent power (KVA) supplied to the circuit.
562
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

7.8K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
7.8K
Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

8.5K
The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
8.5K
Single-pass Transmembrane Proteins01:25

Single-pass Transmembrane Proteins

6.8K
Integral membrane proteins are tightly associated with the cell membrane and play a crucial role in cell communication, signaling, adhesion, and transport of the molecules. Some integral membrane proteins are present only in the membrane monolayer. For example, the enzyme fatty acid amide hydrolase is present in the cytoplasmic side of the membrane monolayer. In contrast, another type of integral membrane protein, also known as a transmembrane protein, spans across the membrane. Transmembrane...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of macrovascular events among patients with ICD-defined neuromyelitis optica in Taiwan.

Frontiers in neurology·2026
Same author

Boron neutron capture therapy for recurrent pediatric sialoblastoma: the first clinical experience and dosimetric considerations for skeletal safety with 4-year follow-up.

Radiation oncology journal·2026
Same author

Reply to Peng and Chen.

Pain·2026
Same author

Relationship Between Tourette Syndrome and Neurodevelopmental Disorders in Taiwan: A Population-Based Cohort Study.

Neuroepidemiology·2026
Same author

The Impact of Teamwork Climate on Hospital Employees' Job Satisfaction and Perceived Healthcare Quality.

Healthcare (Basel, Switzerland)·2026
Same author

Comparative biological evaluation of [<sup>18</sup>F]fluciclovine, [<sup>18</sup>F]FBPA-Fr, and [<sup>18</sup>F]FET for boron neutron capture therapy: Preclinical validation and clinical feasibility.

Nuclear medicine and biology·2026

Related Experiment Video

Updated: Feb 15, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.5K

A practical background correction method for an immediately repeated first-pass radionuclide angiography.

Lien-Hsin Hu1, Liang-Chih Wu1, Chien-Ying Lee1

  • 1Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Journal of the Chinese Medical Association : JCMA
|February 6, 2018
PubMed
Summary

A new method corrects background interference in first-pass radionuclide angiography (FPRNA) after suboptimal bolus injections. This technique improves the accuracy of ejection fraction measurements, avoiding repeat studies and ensuring reliable cardiac function assessment.

Keywords:
Background correctionBackground interferenceBackground subtractionEjection fractionFirst-pass radionuclide angiographyImage processing

More Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.6K
Rejection of Fluorescence Background in Resonance and Spontaneous Raman Microspectroscopy
15:04

Rejection of Fluorescence Background in Resonance and Spontaneous Raman Microspectroscopy

Published on: May 18, 2011

13.6K

Related Experiment Videos

Last Updated: Feb 15, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.5K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.6K
Rejection of Fluorescence Background in Resonance and Spontaneous Raman Microspectroscopy
15:04

Rejection of Fluorescence Background in Resonance and Spontaneous Raman Microspectroscopy

Published on: May 18, 2011

13.6K

Area of Science:

  • Nuclear Medicine
  • Cardiovascular Imaging
  • Radiology

Background:

  • First-pass radionuclide angiography (FPRNA) requires satisfactory bolus injections for accurate results.
  • Suboptimal injections lead to background interference, often necessitating study rescheduling.
  • A novel protocol was developed to correct pre-existing background activity.

Purpose of the Study:

  • To develop and validate a method for correcting background activity in FPRNA.
  • To assess the impact of background correction on ejection fraction (EF) measurements.
  • To improve the reliability of FPRNA by avoiding repeat procedures.

Main Methods:

  • Seventy-four patients undergoing same-day bone scan and FPRNA were analyzed.
  • Ejection fraction (EF) was calculated from initial and repeated injections, with and without background correction.
  • A subset of patients had clearance constants determined for enhanced background correction.

Main Results:

  • The corrected ejection fraction (EF2') showed significantly smaller mean differences compared to the uncorrected EF2 for both left and right ventricles (LV and RV).
  • Mean differences for LV were 1.6 ± 2.1% (corrected) vs. 3.1 ± 2.0% (uncorrected).
  • Mean differences for RV were 1.8 ± 1.8% (corrected) vs. 2.2 ± 1.9% (uncorrected).

Conclusions:

  • Immediate re-administration of bolus injection in FPRNA can underestimate LVEF and RVEF.
  • The developed correction method provides superior results compared to uncorrected data.
  • This protocol enhances the accuracy of FPRNA, particularly when initial injections are suboptimal.